The potent EPA+ formula provides an elevated dose and ratio of EPA relative to DHA along with the omega-6 GLA.
Although EPA is the primary anti-inflammatory fatty acid, the action of GLA is also characterized as anti-inflammatory via its elongation product DGLA.
The complex interactions of essential fatty acids and their eicosanoid products have a significant impact on clinical outcomes. The EPA+ formula provides for ideal cellular phospholipid composition and optimal expression of anti-inflammatory prostanoids, leukotrienes, resolvins, and protectins, thereby encouraging biological homeostasis.
